22nd Century Group Inc XXII:NASDAQ

Last Price$2.35NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/06/21

Today's Change+0.02(0.86%)
Bid (Size)$1.95 (2)
Ask (Size)$2.94 (4)
Day Low / High$2.23 - 2.40
Volume1.5 M

View Biotechnology IndustryPeer Comparison as of 12/06/2021


22nd Century Group Inc ( NASDAQ )

Price: $2.35
Change: +0.02 (0.86%)
Volume: 1.5 M
4:00PM ET 12/06/2021

Viking Therapeutics Inc ( NASDAQ )

Price: $4.97
Change: +0.06 (1.22%)
Volume: 796.5 K
4:00PM ET 12/06/2021

Cortexyme Inc ( NASDAQ )

Price: $12.45
Change: -0.59 (4.52%)
Volume: 812.00
4:00PM ET 12/06/2021


Price: $8.92
Change: +0.38 (4.45%)
Volume: 1.00
8:00PM ET 12/06/2021

Jounce Therapeutics Inc ( NASDAQ )

Price: $7.22
Change: +0.09 (1.26%)
Volume: 337.5 K
4:00PM ET 12/06/2021

Read more news Recent News

22nd Century Group Hires Richard Fitzgerald as CFO
9:04AM ET 11/19/2021 MT Newswires

22nd Century Group (XXII), an agricultural biotechnology company, said Friday that Richard Fitzgerald has been named chief financial officer, effective...

Top Midday Decliners
1:33PM ET 8/30/2021 MT Newswires

Astra Space (ASTR) was trading down 17% by Monday afternoon, with the daily trading volume surging to over 10 million from an average of 3.9 million, after...

22nd Century Group Enters Global Specialty Hops Market, Creating New Unit in the Netherlands
10:36AM ET 8/30/2021 MT Newswires

22nd Century Group (XXII) said Monday it has entered the global specialty hops market, its third plant-based franchise. The company said the venture...

--Cowen Starts 22nd Century Group at Outperform With $5 Price Target
7:43AM ET 7/23/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business Description22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY. View company web site for more details
Address500 Seneca Street
Buffalo, New York 14204
Number of Employees82
Recent SEC Filing11/19/20218-K
Chief Executive OfficerJames A Mish
President & Chief Operating OfficerMichael J. Zercher
Chief Financial OfficerRichard F. Fitzgerald
Vice President-Research & DevelopmentJuan Sanchez Tamburrino

Company Highlights

Price Open$2.33
Previous Close$2.35
52 Week Range$1.54 - 6.07
Market Capitalization$382.4 M
Shares Outstanding162.7 M
SectorHealth Technology
Next Earnings Announcement03/10/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.15
Beta vs. S&P 500N/A
Revenue$26.4 M
Net Profit Margin-82.68%
Return on Equity-38.10%

Analyst Ratings as of 07/22/2021

Consensus RecommendationConsensus Icon
Powered by Factset